NO20021948D0 - Prevensjonsmedikament basert på progesteron og östrogen og fremgangsmåte for fremstilling av dette - Google Patents

Prevensjonsmedikament basert på progesteron og östrogen og fremgangsmåte for fremstilling av dette

Info

Publication number
NO20021948D0
NO20021948D0 NO20021948A NO20021948A NO20021948D0 NO 20021948 D0 NO20021948 D0 NO 20021948D0 NO 20021948 A NO20021948 A NO 20021948A NO 20021948 A NO20021948 A NO 20021948A NO 20021948 D0 NO20021948 D0 NO 20021948D0
Authority
NO
Norway
Prior art keywords
progesterone
estrogen
preparation
drug based
contraceptive drug
Prior art date
Application number
NO20021948A
Other languages
English (en)
Other versions
NO20021948L (no
NO330885B1 (no
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021948(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of NO20021948D0 publication Critical patent/NO20021948D0/no
Publication of NO20021948L publication Critical patent/NO20021948L/no
Publication of NO330885B1 publication Critical patent/NO330885B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
NO20021948A 1999-10-25 2002-04-25 Anvendelse av et preparat som omfatter østradiol og nomegestrolacetat for fremstilling av et prevensjonsprodukt, samt et prevensjonsprodukt. NO330885B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (fr) 1999-10-25 1999-10-25 Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
PCT/FR2000/002952 WO2001030358A1 (fr) 1999-10-25 2000-10-24 Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation

Publications (3)

Publication Number Publication Date
NO20021948D0 true NO20021948D0 (no) 2002-04-25
NO20021948L NO20021948L (no) 2002-06-25
NO330885B1 NO330885B1 (no) 2011-08-08

Family

ID=9542725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021948A NO330885B1 (no) 1999-10-25 2002-04-25 Anvendelse av et preparat som omfatter østradiol og nomegestrolacetat for fremstilling av et prevensjonsprodukt, samt et prevensjonsprodukt.

Country Status (21)

Country Link
EP (2) EP1227815A1 (no)
JP (1) JP5484646B2 (no)
KR (1) KR100549625B1 (no)
CN (1) CN1205936C (no)
AP (1) AP1707A (no)
AU (1) AU784478B2 (no)
BR (1) BR0014952A (no)
CA (1) CA2388857C (no)
CR (1) CR6627A (no)
CZ (1) CZ301982B6 (no)
ES (1) ES2565688T3 (no)
HK (1) HK1048600A1 (no)
HU (1) HU230467B1 (no)
IL (2) IL149141A0 (no)
MX (1) MXPA02004083A (no)
NO (1) NO330885B1 (no)
NZ (1) NZ518308A (no)
OA (1) OA12071A (no)
RU (1) RU2258512C2 (no)
WO (2) WO2001030355A1 (no)
ZA (1) ZA200203399B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
KR100975350B1 (ko) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 사람 락토페리신을 생산하는 형질전환 복제 소 및 이것의생산방법
US20060009428A1 (en) * 2004-07-07 2006-01-12 Wyeth Cyclic progestin regimens and kits
US8663681B2 (en) * 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN103877059A (zh) * 2014-03-26 2014-06-25 邵娜 一种醋酸诺美孕酮片及其制备工艺

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
HU214598B (hu) 1987-09-24 1998-04-28 Jencap Research Ltd Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19529767A1 (de) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphile Verbindungen mit mehreren hydrophilen und hydrophoben Gruppen auf der Basis von Aminobernsteinsäurederivaten
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
DE19536745A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt für eine Scheibenwischervorrichtung eines Fahrzeuges, insbesondere eines Kraftfahrzeuges
DE19536742A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt für eine Scheibenwischvorrichtung eines Fahrzeuges
DE29515703U1 (de) 1995-10-02 1996-02-08 Föhl, Artur, 73614 Schorndorf Drehantriebsvorrichtung für einen Gurtstraffer
JP3616966B2 (ja) 1995-10-02 2005-02-02 エヌエスケー・オートリブ株式会社 シートベルト用リトラクター
DE19536744A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt mit auswechselbarem Wischgummi für einen Fahrzeugscheibenwischer
EP0770338B1 (en) 1995-10-23 2002-09-25 Honda Access Corp. Cap body of a helmet
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
AU2815897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP1007052B1 (en) 1997-08-27 2004-10-13 Ortho-McNeil Pharmaceutical, Inc. Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CN1270521A (zh) * 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂

Also Published As

Publication number Publication date
EP1227815A1 (fr) 2002-08-07
NO20021948L (no) 2002-06-25
CN1382054A (zh) 2002-11-27
WO2001030358A1 (fr) 2001-05-03
RU2002113654A (ru) 2004-01-27
CA2388857A1 (fr) 2001-05-03
HK1048600A1 (zh) 2003-04-11
WO2001030355A1 (fr) 2001-05-03
BR0014952A (pt) 2003-07-29
IL149141A (en) 2008-06-05
AP1707A (en) 2007-02-26
EP2020236B1 (fr) 2016-01-27
CZ301982B6 (cs) 2010-08-25
NZ518308A (en) 2006-01-27
JP5484646B2 (ja) 2014-05-07
AU784478B2 (en) 2006-04-13
AU1033501A (en) 2001-05-08
NO330885B1 (no) 2011-08-08
OA12071A (fr) 2006-05-04
AP2002002485A0 (en) 2002-06-30
CA2388857C (fr) 2011-06-07
PL354518A1 (en) 2004-01-26
HUP0203443A2 (hu) 2003-01-28
KR20020073333A (ko) 2002-09-23
CN1205936C (zh) 2005-06-15
RU2258512C2 (ru) 2005-08-20
JP2003518013A (ja) 2003-06-03
ZA200203399B (en) 2004-02-09
MXPA02004083A (es) 2003-08-20
IL149141A0 (en) 2002-11-10
ES2565688T3 (es) 2016-04-06
HUP0203443A3 (en) 2003-12-29
CZ20021426A3 (cs) 2002-08-14
KR100549625B1 (ko) 2006-02-08
HU230467B1 (hu) 2016-07-28
HK1129564A1 (zh) 2009-12-04
CR6627A (es) 2008-06-18
EP2020236A1 (fr) 2009-02-04

Similar Documents

Publication Publication Date Title
CY2021020I1 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
NO20014504L (no) Anordning og fremgangsmåte for rehabilitering av tinnitus
EE200000211A (et) Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt
NO20030954D0 (no) Fremgangsmåte for å öke testosteron og beslektede konsentrasjoner av steroid hos kvinner
ATE267004T1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
AU3676500A (en) Aligner, microdevice, photomask, exposure method, and method of manufacturing device
DK1242012T3 (da) Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde
AU2458202A (en) Flare measuring method and flare measuring device, exposure method and exposure system, method of adjusting exposure system
PL345695A1 (en) Estradiol-containing patch for transdermal administration of hormones
AU2692500A (en) Semiconductor device and method of manufacture thereof
NO991593L (no) Hormonpreparat bestÕende av en °strogenforbindelse og en progesteronforbindelse
NO20013632L (no) Steroid sulfatase inhibitorer og fremgangsmater for fremstilling og anvendelse av det samme
NO971449D0 (no) Nye hormonelle medikamenter og anvendelse derav for korrigering av östrogen-mangel
IL127129A0 (en) Method of preparation of progesterone tablet for vaginal delivery and tablets so prepared
AU2002217841A1 (en) Neuroactive steroid derivatives and methods of use
AU4395099A (en) Exposure method and device
NO20021948L (no) Prevensjonspreparat basert på et progesteron og et östrogen og en fremgangsmåte for fremstilling av dette
NO20020999L (no) Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer
EP1063563A4 (en) LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF
AU6001599A (en) Semiconductor device and method of manufacture thereof
AU8820198A (en) Method and device for topical administration of substances
AU2001247205A1 (en) Estrogen receptor beta variants and methods of detection thereof
AU2001294947A1 (en) Method and apparatus for temporarily immobilizing a local area of tissue
AU4825200A (en) Oral steroidal hormone compositions and methods of use
FR2743561B1 (fr) Derives de steroides, procede de preparation et utilisation en therapeutique

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAMEX HQ UK LIMITED, GB

MK1K Patent expired